CD4 and malaria: As a result, World Health Organization (WHO) recommends cotrimoxazole preventive therapy (CPT) lifelong for PLHIV in resource-limited settings where malaria and, or severe bacterial infections are highly prevalent, irrespectively of their CD4 count.